The butanol fraction of Eclipta prostrata (Linn) increases the formation of brain acetylcholine and decreases oxidative stress in the brain and serum of cesarean-derived rats

Nutrition Research

Volumn 30, Issue 8, 2010, Pages 579-584

  Kim, Dae Ik ^a   Lee, Sung Hyen ^b,c   Hong, Joo Heon ^d   Lillehoj, Hyun Soon ^b   Park, Hong Ju ^c   Rhie, Seung Gyo ^e   Lee, Gun Soon ^c  

^a Bio Industry Center   (South Korea)

^b AGRICULTURAL RESEARCH SERVICE   (United States)

^c National Institute of Animal Science   (South Korea)

^d Catholic University of Daegu   (South Korea)

^e Suwon University   (South Korea)

Author keywords

Antidementia; Antioxidant; Eclipta prostrata; Neurotransmitter; Rat

Indexed keywords

ACETYLCHOLINE; ACETYLCHOLINESTERASE; AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME B; BUTANOL; ECLIPTA PROSTRATA EXTRACT; SUPEROXIDE; SUPEROXIDE DISMUTASE;

ACETYLCHOLINE BRAIN LEVEL; ANIMAL EXPERIMENT; ANTIOXIDANT ACTIVITY; ARTICLE; CESAREAN SECTION; CONTROLLED STUDY; DEMENTIA; DIET SUPPLEMENTATION; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG EFFICACY; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; HAIRLESS RAT; INTERMETHOD COMPARISON; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT;

ACETYLCHOLINE; ANIMALS; ANTIOXIDANTS; BRAIN; ECLIPTA; ESTERASES; MALE; MONOAMINE OXIDASE; OXIDATIVE STRESS; PLANT EXTRACTS; RATS; RATS, SPRAGUE-DAWLEY; SUPEROXIDE DISMUTASE; SUPEROXIDES;

ECLIPTA; ECLIPTA PROSTRATA; MUS; RATTUS;

EID: 77956835344     PISSN: 02715317     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nutres.2010.08.001     Document Type: Article

References (51)

1. Harman D. Aging: phenomena and theories. Ann N Y Acad Sci 1998, 854:1-7.
2. Ho Y.S., So K.F., Chang R.C.C. Anti-aging herbal medicine-how and why can they be used in aging-associated neurodegenerative diseases?. Ageing Res Rev 2010, 9:354-362.
3. Loewi O. Über humerole übertragbarkeit der herznervenwirkung. I Mitteilung Pflugers Arch 1921, 189:239-242.
4. Jones B.E. From waking to sleeping: neuronal and chemical substrates. Trends Pharmacol Sci 2005, 26:578-586.
5. Himmelheber A.M., Sarter M., Bruno J.P. Increases in cortical acetylcholine release during sustained attention performance in rats. Brain Res Cogn Brain Res 2000, 9:313-325.
6. Purves D., Augustine G.J., Fitzpatrick D., Hall W.C., LaMantia A.S., McNamara J.O., et al. Neuroscience 2008, Sinauer Associates, Sunderland.
7. Tago H., McGeer P.L., McGeer E.G. Acetylcholinesterase fibers and the development of senile plaques. Brain Res 1987, 406:363-369.
8. Davies P., Maloney A.J. Selective loss of central cholinergic neurons in Alzheimer's disease. Lancet 1976, 2:1403.
9. Perry E.K., Perry R.H., Blessed G., Tomlinson B.E. Necropsy evidence of central cholinergic deficits in senile dementia. Lancet 1977, 1:189.
10. Whitehouse P.J., Price D.L., Struble R.G., Clark A.W., Coyle J.T., Delon M.R. Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain. Science 1982, 215:1237-1239.
11. Bierer L.M., Haroutunian V., Gabriel S., Knott P.J., Carlin L.S., Purohit D.P., et al. Neurochemical correlates of dementia severity in Alzheimer's disease: relative importance of the cholinergic deficits. J Neurochem 1995, 64:749-760.
12. Harman D. Aging: a theory based on free radical and radiation chemistry. J Gerontol 1956, 11:298-300.
13. Prasad K.N., Cole W.C., Hovland A.R., Prasad K.C., Nahreini P., Kumar B., et al. Multiple antioxidants in the prevention and treatment of neurodegenerative disease: analysis of biologic rationale. Curr Opin Neurol 1999, 12:761-770.
14. James L.E., Fogler K.A., Tauber S.K. Recognition memory measures yield disproportionate effects of aging on learning face-name associations. Psychol. Aging 2008, 23:657-664.
15. Alzheimer's Association Alzheimer's disease facts and figures. Alzheimers Dement 2008, 4:110-133.
16. Sandhya B., Thomas S., Isabel W., Shenbagarathai R. Ethnomedicinal plants used by the Valaiyan community of Piranmalai hills (reserved forest), Tamil Nadu, India: A pilot study. Afr J Traditional Compl Alter Med 2006, 3:101-114.
17. Shin J.Y. Principles and practice of eastern medicine 2009, Hagwonsa, Seoul.
18. Council of Scientific and Industrial Research The wealth of India, raw materials 1952, CSIR, New Delhi.
19. Thakur V.D., Mengi S.A. Neuropharmacological profile of Eclipta alba (Linn.). Hassk J Ethnopharmacol 2005, 102:23-31.
20. Lee S., Kim D., Park H., Lillehoj H. Supplementary effect of Eclipta on the serum lipid metabolism in rats. Atherosclerosis 2008, 9:256.
21. Kim D.I., Lee S.H., Choi J.H., Lillehoj H.S., Yu M.H., Lee G.S. The butanol fraction of Eclipta prostrata (Linn) effectively reduces serum lipid levels and improves antioxidant activities in CD rats. Nutr Res 2008, 28:550-554.
22. Khanna V.G., Kannabiran K. Larvicidal effect of Hemidesmus indicus, Gymnema sylvestre, and Eclipta prostrata against Culex qinquifaciatus mosquito larvae. Afr J Biotechnol 2007, 6:307-311.
23. Choi Y.H., Kim Y.S., Yeo S.J., Roh S.H., Jeong Y.C., Kang J.S., et al. Ameliorating effect of balloon flower saponin on the ethanol-induced memory impairment in mice. Phytotherapy Res 2008, 22:973-976.
24. Badmus J.A., Odunola O.A., Obuotor E.M., Oyedapo O.O. Phytochemicals and in vitro antioxidant potentials of defatted methanolic extract of Holarrhena floribunda leaves. Afr J Biotechnol 2010, 9:340-346.
25. American Institute of Nutrition Report of the AIN Ad Hoc Committee Standards for Nutritional Studies. J Nutr 1977, 107:1340-1348.
26. Lee S.H., Park H.J., Chun H.K., Cho S.Y., Jung H.J., Cho S.M. Dietary phytic acid improves serum and hepatic lipid levels in aged ICR mice fed a high-cholesterol diet. Nutr Res 2007, 27:505-510.
27. Lee S.H., Park H.J., Cho S.Y., Jung H.J., Cho S.M., Cho S.M. Effects of dietary phytic acid on serum and hepatic lipid levels in diabetic KK mice. Nutr Res 2005, 25:869-876.
28. Choi J.H., Yu B.P. The effect of food restriction on kidney membrane structures of aging rats. Age 1989, 12:133-136.
29. Hestrin S. The reaction of acetylcholine and other carboxylic acid derivatives with hydroxylamine and its analytical application. J Biol Chem 1949, 180:249-261.
30. Galgani F., Bocquene G., Cadiou Y. Evidence of variation in cholinesterase activity in fish along a pollution gradient in the North Sea. Mar Ecol Progr Ser 1992, 91:77-82.
31. Kalaria R.N., Mitchell M.J., Harik S.I. Correlation of 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine neurotoxicity with blood-brain barrier monoamine oxidase activity. Proc Natl Acad Sci 1987, 84:3521-3525.
32. McCord J.M., Fridovch I. Superoxide dismutase. An enzymic function for erythro cuprein (hemocuprein). J B Chem 1969, 244:6049-6055.
33. Chan P.C., Bielski B.H.J. Enzyme catalyzed free radical reactions with nicotinamide adenine nucleotide. J B Chem 1974, 249:1317-1319.
34. Oyanagui Y. Reevaluation of assay methods and establishment of Kit for superoxide dismutase activity. Anal Biochem 1984, 42:290-296.
35. Rigo A., Rotilio G. Simultaneous determination of superoxide dismutase and catalase in biological materials by polarography. Anal Biochem 1977, 81:157-166.
36. Dunnett C.W. A multiple comparisons procedure for comparing several treatments with a control. J Am Statistic Assoc 1955, 50:1096-1121.
37. Sokal R.R., Rohlf F.J. The principles and practice of statistics in biological research 1969, Freeman and Co, San Francisco.
38. Terry R.D., Katzman R. Senile dementia of the Alzheimer type. Ann Neurol 1983, 14:497-506.
39. Quirion R. Cholinergic markers in Alzheimer disease and the autoregulation of acetylcholine release. J Psychiatry Neurosci 1993, 18:226-234.
40. Herholz K., Weisenbach S., Hilker R., Heiss W. Measuring cortical acetylcholine esterase activity by PET in dementia. Clinical Correlates Neuro RX 2006, 3:410.
41. Edmondson D.E., Binda C., Mattevi A. Structural insights into the mechanism of amine oxidation by monoamine oxidases A and B. Arch Biochem Biophy 2007, 464:269-276.
42. Muck-Seler D., Presecki P., Mimica N., Mustapic M., Pivac N., Babic A., et al. Platelet serotonin concentration and monoamine oxidase type B activity in female patients in early, middle and late phase of Alzheimer's disease. Prog Neuropsychopharmacol Biol Psychiatry 2009, 33:1226-1231.
43. Wilkinson B.L., Landreth G.E. The microglial NADPH oxidase complex as a source of oxidative stress in Alzheimer's disease. J Neuroinflammation 2006, 3:30.
44. Pratico D., Uryu K., Leight S., Trojanoswki J.Q., Lee V.M. Increased lipid peroxidation precedes amyloid plaque formation in an animal model of Alzheimer amyloidosis. J Neurosci 2001, 21:4183-4187.
45. Pratico D., Sung S. Lipid peroxidation and oxidative imbalance: early functional events in Alzheimer's disease. J Alzheimers Dis 2004, 6:171-175.
46. Xie Z., Wei M., Morgan T.E., Fabrizio P., Han D., Finch C.E., et al. Peroxynitrite mediates neurotoxicity of amyloid beta-peptide1-42- and lipopolysaccharide-activated microglia. J Neurosci 2002, 22:3484-3492.
47. Fuhrman B., Partoush A., Aviram M. Acetylcholine esterase protects LDL against oxidation. Biochem Biophys Res Commun 2004, 322:974-978.
48. Dumont M., Wille E., Stack C., Calingasan N.Y., Beal M.F., Lin M.T. Reduction of oxidative stress, amyloid deposition, and memory deficit by manganese superoxide dismutase overexpression in a transgenic mouse model of Alzheimer's disease. FASEB 2009, 23:2459-2466.
49. Rangineni V., Sharada D., Saxena S. Diuretic, hypotensive, and hypocholesterolemic effects of Eclipta alba in mild hypertensive subjects: a pilot study. J Med Food 2007, 10:143-148.
50. Choi J.H., Yu B.P. Brain synaptosomal aging: free radicals and membrane fluidity. Free Radic Biol Med 1995, 18:133-139.
51. Knight J.A. Reactive oxygen species and the neurodegenerative disorders. Ann Clin Lab Sci 1997, 27:11-25.